Max Healthcare NRC approves 3,61,827 employee stock options
Max Healthcare Institute’s NRC approved 3,61,827 stock options under the 2022 scheme. Grants include 1,61,827 options at ₹800 and 2,00,000 options at ₹350. Vesting occurs over one to five years, with a three-year exercise window post-vesting.
*this image is generated using AI for illustrative purposes only.
Max Healthcare Institute Limited Max Healthcare Institute has approved the grant of 3,61,827 stock options to eligible employees under its Employee Stock Option Scheme 2022. The Nomination and Remuneration Committee (NRC) finalized the grants during a meeting held on August 13, 2026, aligning compensation incentives with long-term performance metrics.
The approval covers two separate tranches of options, each governed by distinct pricing structures but unified under the same vesting framework. The larger tranche consists of 2,00,000 options granted at an exercise price of ₹350 per option. The second tranche comprises 1,61,827 options with a higher exercise price of ₹800 per option. Each stock option is convertible into one fully paid-up equity share with a face value of ₹10.
Grant Structure and Vesting Terms
Both sets of options adhere to identical vesting and exercise timelines as determined by the NRC. The options are subject to pre-vesting conditions and will vest not earlier than one year and not later than five years from the date of grant. Once vested, employees have a window of three years to exercise the options.
| Particulars | Tranche 1 | Tranche 2 |
|---|---|---|
| Number of Options | 1,61,827 | 2,00,000 |
| Exercise Price | ₹800 | ₹350 |
| Vesting Window | 1-5 years | 1-5 years |
| Exercise Period | 3 years post-vesting | 3 years post-vesting |
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The NRC meeting commenced at 7:50 am and concluded at 8:20 am. The company confirmed that these grants are administered under the MHIL ESOP 2022, which complies with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Historical Stock Returns for Max Healthcare Institute
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.63% | -6.13% | -8.35% | -4.62% | -19.58% | +207.63% |
How might the dual-tier exercise pricing structure impact employee retention rates and potential dilution for existing shareholders?
What specific long-term performance metrics has Max Healthcare tied to the vesting of these options, and how do they align with the company's 2026-2030 strategic goals?
Given the significant difference in exercise prices (₹350 vs ₹800), what does this suggest about the company's internal valuation of different employee roles or seniority levels?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
